CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 11.36: safe zone
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
853.74MCHF1.07B · vs all stocks (USD)
Trailing P/E
116.90xvs Medical Devices peers
Revenue (TTM)
141.96MCHF177.24M · vs all stocks (USD)
Profit Margin
5.13%vs Medical Devices peers
Beta
0.7610xvs all stocks
52-Week Change
-16.85%vs all stocks
Market Capitalization
853.74MCHF1.07B · vs all stocks (USD)
Enterprise Value
835.67MCHF1.04B · vs all stocks (USD)
Trailing P/E
116.90xvs Medical Devices peers
Forward P/E
45.35xvs Medical Devices peers
Price to Sales (TTM)
5.30xvs Medical Devices peers
Price to Book (MRQ)
13.36xvs Medical Devices peers
Enterprise to Revenue
5.58xvs Medical Devices peers
Enterprise to EBITDA
93.16xvs Medical Devices peers
Profit Margin
5.13%vs Medical Devices peers
Operating Margin
5.61%vs Medical Devices peers
Return on Assets (TTM)
1.91%vs Medical Devices peers
Return on Equity (TTM)
3.02%vs Medical Devices peers
Revenue (TTM)
141.96MCHF177.24M · vs all stocks (USD)
Revenue per Share (TTM)
4.56CHFUpdated Aug 21, 2026Quarterly Revenue Growth
45.50%vs Medical Devices peers
Gross Profit (TTM)
122.60MCHF153.08M · vs all stocks (USD)
EBITDA (TTM)
8.97MCHF11.20M · vs all stocks (USD)
Net Income (TTM)
7.22MCHF9.02M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
0.00%vs Medical Devices peers
Operating Cash Flow (TTM)
-466.25KCHF-582.13K · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00CHFUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
146.06MCHFFY2025 · Dec 31, 2025Cost of Goods Sold
16.66MCHFFY2025 · Dec 31, 2025Gross Profit
129.40MCHFFY2025 · Dec 31, 2025Operating Income
8.95MCHF11.17M · vs all stocks (USD)
Pre-tax Income
5.01MCHFFY2025 · Dec 31, 2025Income Tax Expense
2.55MCHFFY2025 · Dec 31, 2025Net Income
2.55MCHFFY2025 · Dec 31, 2025EBIT
5.38MCHFFY2025 · Dec 31, 2025EBITDA (Income Statement)
8.75MCHFFY2025 · Dec 31, 2025Research & Development
10.67MCHFFY2025 · Dec 31, 2025Selling, General & Administrative
81.63MCHFFY2025 · Dec 31, 2025Non-operating Interest Income
102.00KCHFFY2025 · Dec 31, 2025Non-operating Interest Expense
367.00KCHFFY2025 · Dec 31, 2025Net Income from Continuing Operations
5.10MCHFFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CHFFY2025 · Dec 31, 2025Operating Cash Flow
-18.96MCHFFY2025 · Dec 31, 2025Free Cash Flow
-21.40MCHFFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
19.77MCHFFY2025 · Dec 31, 2025Starting Profit (CF Statement)
5.10MCHFFY2025 · Dec 31, 2025Stock-based Compensation
4.20MCHFFY2025 · Dec 31, 2025Other Non-cash Items
4.29MCHFFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-22.61MCHFFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-9.94MCHFFY2025 · Dec 31, 2025Capital Expenditures
-2.44MCHFFY2025 · Dec 31, 2025Net Intangibles (CF)
0.00CHFFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.44MCHFFY2025 · Dec 31, 2025Net Financing Cash Flow
2.19MCHFFY2025 · Dec 31, 2025Shares Outstanding
39.15MSharesUpdated Aug 21, 2026Float Shares
29.66MSharesUpdated Aug 21, 2026% Held by Insiders
28.74%vs all stocks
% Held by Institutions
22.00%vs all stocks
Total Cash (MRQ)
19.02MCHF23.74M · vs all stocks (USD)
Total Debt (MRQ)
1.39MCHF1.74M · vs all stocks (USD)
Current Ratio (MRQ)
1.96xvs Medical Devices peers
Book Value per Share (MRQ)
1.75CHFUpdated Aug 21, 2026Total Assets
133.88MCHF167.15M · vs all stocks (USD)
Total Current Assets
82.67MCHFFY2025 · Dec 31, 2025Total Liabilities
49.39MCHFFY2025 · Dec 31, 2025Total Non-current Assets
51.21MCHFFY2025 · Dec 31, 2025Total Non-current Liabilities
7.25MCHFFY2025 · Dec 31, 2025Total Current Liabilities
42.14MCHFFY2025 · Dec 31, 2025Cash
19.02MCHFFY2025 · Dec 31, 2025Cash & Cash Equivalents
19.02MCHFFY2025 · Dec 31, 2025Accounts Receivable
30.21MCHFFY2025 · Dec 31, 2025Inventory
21.35MCHFFY2025 · Dec 31, 2025Accounts Payable
13.81MCHFFY2025 · Dec 31, 2025Short-term Debt
653.00KCHFFY2025 · Dec 31, 2025Long-term Debt
737.00KCHFFY2025 · Dec 31, 2025Common Stock (Book)
3.23MCHFFY2025 · Dec 31, 2025Retained Earnings
-17.38MCHFFY2025 · Dec 31, 2025Total Shareholders' Equity
84.48MCHF105.48M · vs all stocks (USD)
Treasury Stock
0.00CHFFY2025 · Dec 31, 202552-Week Low
17.69CHFUpdated Aug 21, 202652-Week High
34.20CHFUpdated Aug 21, 202652-Week Change
-16.85%vs all stocks
Beta
0.7610xvs all stocks
50-Day MA
20.71CHFUpdated Aug 21, 2026200-Day MA
24.11CHFUpdated Aug 21, 2026Avg 10-Day Volume
200.41KSharesUpdated Aug 21, 2026Avg 30-Day Volume
171.83KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.2000CHFUpdated Aug 21, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 9,020,504.063Operating Cash Flow (USD, TTM): -582,133.94
Financial Health
Altman Z-Score 11.36: safe zoneNotable
Altman Z-Score: 11.36
Consistent revenue growth patternNotable
Growth Consistency Score: 0.52
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Blue Jet Healthcare Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Akums Drugs & Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Anhui Wanbang Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alto Neuroscience Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Lexicon Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Changchun BCHT Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Dezhan Health Care Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lifetech Scientific Corporation
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Kanion Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Haohai Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Bondada Engineering Pvt. Ltd.
4 interpretationsOperating Income Growing With Multi-Year Revenue GrowthIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedLow Fixed-Asset Share With Elevated Turnover
Inox India Ltd.
4 interpretationsOperating Income Growing With Multi-Year Revenue GrowthIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedLow Fixed-Asset Share With Elevated Turnover
PhosAgro Public Joint Stock Company
4 interpretationsOperating Income Growing With Multi-Year Revenue GrowthIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedLow Fixed-Asset Share With Elevated Turnover